Pre- and Post-Implant Endoscopy in Left Ventricular Assist Device Recipients: A Single-Center Experience
- PMID: 38463148
- PMCID: PMC10923248
- DOI: 10.14740/gr1661
Pre- and Post-Implant Endoscopy in Left Ventricular Assist Device Recipients: A Single-Center Experience
Abstract
Background: Gastrointestinal bleeding (GIB) is common in left ventricular assist devices (LVADs) patients, but the optimal screening approach before LVAD implantation is still unclear. The aim of the study was to describe our experience with pre- and post-LVAD implantation endoscopic screening and subsequent GI bleeding in this cohort.
Methods: A retrospective review was conducted among all patients who underwent LVAD implantation at Saint Luke's Hospital, between 2010 and 2020. The data were reviewed to determine the yield and safety of endoscopic procedures performed within 1 month before LVAD placement and the incidence of GIB within 1 year after implantation.
Results: A total of 167 LVAD patients met the inclusion criteria, and 23 underwent pre-implantation endoscopic evaluation. Angiodysplasia had a significantly higher odds ratio (OR) of 9.41 (95% confidence interval (CI): 2.01 - 44.09) in post-LVAD endoscopy, while there was no significant difference in bleeding from other sources such as peptic ulcer disease or diverticular bleeding. There was no difference in the incidence of GIB in patients who underwent endoscopic evaluation pre-LVAD compared to post-LVAD GIB (32.6% vs. 39.1%, P = 0.64). Endoscopy was well-tolerated in this cohort, and argon plasma coagulation was the most commonly used intervention to achieve hemostasis.
Conclusions: According to our results, we recommend against routine pre-LVAD endoscopic screening. Instead, we suggest an individualized approach, where decisions are made on a case-by-case basis.
Keywords: Angiodysplasias; Endoscopy; Gastrointestinal bleeding; Left ventricular assist device.
Copyright 2024, Mohamed et al.
Conflict of interest statement
All other authors have no conflict of interest to disclose.
Figures




Similar articles
-
Does endoscopic intervention prevent subsequent gastrointestinal bleeding in patients with left ventricular assist devices? A retrospective study.World J Gastroenterol. 2021 Jul 7;27(25):3877-3887. doi: 10.3748/wjg.v27.i25.3877. World J Gastroenterol. 2021. PMID: 34321851 Free PMC article.
-
Pre-left ventricular assist device endoscopic evaluation does not reduce the risk of later gastrointestinal bleeding: a multicenter study.Ann Gastroenterol. 2024 May-Jun;37(3):313-320. doi: 10.20524/aog.2024.0878. Epub 2024 Apr 10. Ann Gastroenterol. 2024. PMID: 38779638 Free PMC article.
-
Clinical Predictors for Repeat Hospitalizations in Left Ventricular Assist Device (LVAD) Patients With Gastrointestinal Bleeding.Gastroenterology Res. 2018 Apr;11(2):100-105. doi: 10.14740/gr972w. Epub 2018 Apr 7. Gastroenterology Res. 2018. PMID: 29707076 Free PMC article.
-
Gastrointestinal bleeding on continuous-flow left ventricular assist device therapy.ESC Heart Fail. 2023 Aug;10(4):2214-2224. doi: 10.1002/ehf2.14433. Epub 2023 Jun 15. ESC Heart Fail. 2023. PMID: 37322822 Free PMC article. Review.
-
Clinical Approach to Manage Gastrointestinal Bleeding with a Left Ventricular Assist Device (LVAD).Cureus. 2019 Dec 10;11(12):e6341. doi: 10.7759/cureus.6341. Cureus. 2019. PMID: 31938629 Free PMC article. Review.
References
-
- Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, Bogaev RC. et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2011;30(8):849–853. doi: 10.1016/j.healun.2011.03.008. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous